Close Menu

NEW YORK – Luminex reported after the close of the market on Monday that its fourth quarter revenues rose 12 percent year over year, slightly above its preliminary estimates announced last month.

For the three months ended Dec. 31, 2019, the firm said revenues rose to $90.5 million compared to $81.1 million a year ago, and short of Wall Street analysts' consensus estimate of $90.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.